(2013) revealed SAA1 to have a dual role in glioma migration regulation, although the mechanism is unclear, and upregulated SAA1 levels in human glioblastomas were suggested to create a high‐inflammation microenvironment (Knebel et al., 2017). The gene discussed is SAA1; the disease is central nervous system cancer.